480 related articles for article (PubMed ID: 33372157)
1. Filling the gaps in the global prevalence map of clinical antimicrobial resistance.
Oldenkamp R; Schultsz C; Mancini E; Cappuccio A
Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33372157
[TBL] [Abstract][Full Text] [Related]
2. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
Antimicrobial Resistance Collaborators
Lancet; 2022 Feb; 399(10325):629-655. PubMed ID: 35065702
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial resistance among GLASS pathogens in conflict and non-conflict affected settings in the Middle East: a systematic review.
Truppa C; Abo-Shehada MN
BMC Infect Dis; 2020 Dec; 20(1):936. PubMed ID: 33297983
[TBL] [Abstract][Full Text] [Related]
4. Global forecast of antimicrobial resistance in invasive isolates of Escherichia coli and Klebsiella pneumoniae.
Alvarez-Uria G; Gandra S; Mandal S; Laxminarayan R
Int J Infect Dis; 2018 Mar; 68():50-53. PubMed ID: 29410253
[TBL] [Abstract][Full Text] [Related]
5. Trends and relationship between antimicrobial resistance and antibiotic use in Xinjiang Uyghur Autonomous Region, China: Based on a 3 year surveillance data, 2014-2016.
Wushouer H; Zhang ZX; Wang JH; Ji P; Zhu QF; Aishan R; Shi LW
J Infect Public Health; 2018; 11(3):339-346. PubMed ID: 29017750
[TBL] [Abstract][Full Text] [Related]
6. Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study.
Temkin E; Fallach N; Almagor J; Gladstone BP; Tacconelli E; Carmeli Y;
Lancet Glob Health; 2018 Sep; 6(9):e969-e979. PubMed ID: 30103998
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial Resistance Surveillance in Low- and Middle-Income Countries: Progress and Challenges in Eight South Asian and Southeast Asian Countries.
Gandra S; Alvarez-Uria G; Turner P; Joshi J; Limmathurotsakul D; van Doorn HR
Clin Microbiol Rev; 2020 Sep; 33(3):. PubMed ID: 32522747
[TBL] [Abstract][Full Text] [Related]
8. Trends in antimicrobial resistance of bacterial pathogens in Harare, Zimbabwe, 2012-2017: a secondary dataset analysis.
Mhondoro M; Ndlovu N; Bangure D; Juru T; Gombe NT; Shambira G; Nsubuga P; Tshimanga M
BMC Infect Dis; 2019 Aug; 19(1):746. PubMed ID: 31455256
[TBL] [Abstract][Full Text] [Related]
9. Global antimicrobial-resistance drivers: an ecological country-level study at the human-animal interface.
Allel K; Day L; Hamilton A; Lin L; Furuya-Kanamori L; Moore CE; Van Boeckel T; Laxminarayan R; Yakob L
Lancet Planet Health; 2023 Apr; 7(4):e291-e303. PubMed ID: 37019570
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of tigecycline and comparators (2014-2016) among key WHO 'priority pathogens' and longitudinal assessment (2004-2016) of antimicrobial resistance: a report from the T.E.S.T. study.
Seifert H; Blondeau J; Dowzicky MJ
Int J Antimicrob Agents; 2018 Oct; 52(4):474-484. PubMed ID: 30012439
[TBL] [Abstract][Full Text] [Related]
11. Global antimicrobial resistance: a system-wide comprehensive investigation using the Global One Health Index.
Zhou N; Cheng Z; Zhang X; Lv C; Guo C; Liu H; Dong K; Zhang Y; Liu C; Chang YF; Chen S; Guo X; Zhou XN; Li M; Zhu Y
Infect Dis Poverty; 2022 Aug; 11(1):92. PubMed ID: 35996187
[TBL] [Abstract][Full Text] [Related]
12. The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis.
Antimicrobial Resistance Collaborators
Lancet Glob Health; 2024 Feb; 12(2):e201-e216. PubMed ID: 38134946
[TBL] [Abstract][Full Text] [Related]
13. The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis.
European Antimicrobial Resistance Collaborators
Lancet Public Health; 2022 Nov; 7(11):e897-e913. PubMed ID: 36244350
[TBL] [Abstract][Full Text] [Related]
14. Surveillance and comparison of antimicrobial susceptibility patterns of ESKAPE organisms isolated from patients with bacteraemia in South Africa, 2016 - 2017.
Ismail H; Lowman W; Govind CN; Swe Swe-Han K; Maloba MRB; Bamford C; Perovic O
S Afr Med J; 2019 Nov; 109(12):934-940. PubMed ID: 31865955
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial resistance among GLASS priority pathogens from Pakistan: 2006-2018.
Saeed DK; Farooqi J; Shakoor S; Hasan R
BMC Infect Dis; 2021 Dec; 21(1):1231. PubMed ID: 34876041
[TBL] [Abstract][Full Text] [Related]
16. Prospective multi-center evaluation on risk factors, clinical characteristics and outcomes due to carbapenem resistance in
Liu Y; Wang Q; Zhao C; Chen H; Li H; Wang H; Cares Network OBOT
J Med Microbiol; 2020 Jul; 69(7):949-959. PubMed ID: 32584215
[No Abstract] [Full Text] [Related]
17. Accumulation of Antibiotic Resistance Genes in Carbapenem-Resistant
Douraghi M; Kenyon JJ; Aris P; Asadian M; Ghourchian S; Hamidian M
mSphere; 2020 Apr; 5(2):. PubMed ID: 32269158
[TBL] [Abstract][Full Text] [Related]
18. Genetic diversity and risk factors for the transmission of antimicrobial resistance across human, animals and environmental compartments in East Africa: a review.
Katale BZ; Misinzo G; Mshana SE; Chiyangi H; Campino S; Clark TG; Good L; Rweyemamu MM; Matee MI
Antimicrob Resist Infect Control; 2020 Aug; 9(1):127. PubMed ID: 32762743
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance in South Korea: A report from the Korean global antimicrobial resistance surveillance system (Kor-GLASS) for 2017.
Liu C; Yoon EJ; Kim D; Shin JH; Shin JH; Shin KS; Kim YA; Uh Y; Kim HS; Kim YR; Jeong SH
J Infect Chemother; 2019 Nov; 25(11):845-859. PubMed ID: 31311694
[TBL] [Abstract][Full Text] [Related]
20. Trends of major antimicrobial resistance phenotypes in enterobacterales and gram-negative non-fermenters from ATLAS and EARS-net surveillance systems: Italian vs. European and global data, 2008-2018.
Rossolini GM; Bochenska M; Fumagalli L; Dowzicky M
Diagn Microbiol Infect Dis; 2021 Dec; 101(4):115512. PubMed ID: 34419741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
